All In Biotech

Drug Trial Radar · NCT07732309

A Study of ATG-201 in Adult Participants With Autoimmune Diseases

A Phase I, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Efficacy of ATG-201 in Adult Participants With Autoimmune Diseases

Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

149

Planned (sponsor's estimate)

Start

Sep 26, 2026

Primary completion

Dec 1, 2028

Study completion Jun 1, 2029

Sponsor

Lead sponsor
Antengene Biologics LimitedIndustry
Sponsor type
Industry
First posted
Jul 28, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase I, open-label study of ATG-201 in participants with autoimmune diseases.

Conditions

  • Systemic Lupus Erythematosus
  • Systemic Sclerosis (SSc)
  • Sjogren's Disease
  • Autoimmune Diseases

Interventions

  • ATG-201Drug

    ATG-201 is a recombinant, human IgG1-like TCE that simultaneously binds to human CD3 and CD19.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and TolerabilitySafety and TolerabilityTime frame: 48 weeks

Locations

22 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Bengbu Medical University

    Bengbu, Anhui, China · Not yet recruiting

  • The First Affiliated Hospital of University of Science and Technology of China

    Hefei, Anhui, China · Not yet recruiting

  • Peking University People's Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • The First Affiliated Hospital of Xiamen University

    Xiamen, Fujian, China · Not yet recruiting

  • Nanfang Hospital of Southern Medical Universit

    Guangzhou, Guangdong, China · Not yet recruiting

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen Universit

    Guangzhou, Guangdong, China · Not yet recruiting

  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine

    Guangzhou, Guangdong, China · Not yet recruiting

  • The First Affiliated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, China · Not yet recruiting

  • The Third Affiliated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, China · Not yet recruiting

  • The First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, China · Not yet recruiting

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China · Not yet recruiting

  • Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology

    Wuhan, Hubei, China · Not yet recruiting

  • Xiangya Hospital of Central South University

    Changsha, Hunan, China · Not yet recruiting

  • Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School

    Nanjing, Jiangsu, China · Not yet recruiting

  • Nuclear Industry General Hospital

    Suzhou, Jiangsu, China · Not yet recruiting

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China · Not yet recruiting

  • Linyi People's Hospital

    Linyi, Shandong, China · Not yet recruiting

  • Huashan Hospital Affiliated to Fudan University

    Shanghai, Shanghai Municipality, China · Not yet recruiting

  • Renji Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, China · Not yet recruiting

  • The First Hospital of Shanxi Medical University

    Taiyuan, Shanxi, China · Not yet recruiting

  • The Second Affiliated Hospital of Xi'an Jiaotong University

    Xi’an, Shanxi, China · Not yet recruiting

  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.